FDA approves another generic abortion pill, prompting outrage from conservatives

The FDA's recent approval of another generic version of the abortion pill mifepristone has sparked significant backlash from conservative groups and politicians, particularly those aligned with the Trump administration. This decision is crucial as it highlights the ongoing tensions surrounding reproductive rights in the U.S., with many viewing it as a direct challenge to anti-abortion efforts. The approval not only expands access to abortion services but also intensifies the debate over women's rights and healthcare.